Tesofensine is an oral, investigational small molecule, not a peptide, that acts as a triple monoamine reuptake inhibitor, meaning it slows the reabsorption of three brain signalling chemicals at once: serotonin, noradrenaline and dopamine. Originally developed for Alzheimer's and Parkinson's disease, it was redirected toward obesity research after unexpected weight loss was observed in early trials. In Phase 2 studies, and a completed Phase 3 obesity trial (Saniona/Medix, Mexico, reported 2018) that met its endpoints, it has been studied for appetite suppression and body-weight reduction. It is still not approved by the FDA, EMA or any major regulator for any use. At Menscape Clinic in Bangkok, our physicians review it on an individual basis as part of a broader, supervised weight-management conversation for men.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Weight-Loss Management
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
Tesofensine is an oral small-molecule drug, not a peptide, classed as a triple monoamine reuptake inhibitor. It slows the reuptake of serotonin, noradrenaline and dopamine in the brain, raising the available levels of these neurotransmitters that help regulate appetite and mood. It was first developed for neurological conditions, including Alzheimer's and Parkinson's disease, and was later studied for obesity after patients in those trials lost weight. Tesofensine remains an investigational compound: it has completed Phase 2 trials and a Phase 3 obesity registration trial (Saniona/Medix, Mexico, reported 2018) that met its endpoints, but it is not approved for sale by the FDA, the EMA or any major regulator. Anything you read about it should be understood as research, not settled medicine.
/)
By reducing the reuptake of three appetite-related brain chemicals at once, tesofensine is thought to strengthen satiety signalling so the brain registers fullness sooner and hunger less often. Animal research suggests this involves dopamine and adrenergic pathways that dampen the drive to eat, and small human studies have explored a possible modest effect on energy expenditure. The honest position is that the appetite-suppression effect is the best-supported in humans, while the energy-expenditure and metabolic effects rest on limited data. Its triple-monoamine action is also the reason cardiovascular and mood effects, such as raised heart rate and blood pressure, are watched carefully in trials.
/)
In its clinical trials, tesofensine was studied in adults with obesity who were following a reduced-calorie diet, not in people seeking cosmetic or modest weight changes. At Menscape Clinic in Bangkok we see men, including expat and visiting patients, who want a medically supervised approach to weight that goes beyond willpower. Tesofensine is only one possible topic in that conversation, and it is not suitable for everyone. Men with cardiovascular disease, uncontrolled high blood pressure, certain psychiatric conditions, or those taking interacting medications such as other monoamine-affecting drugs would generally not be considered candidates. A physician assessment decides whether it is even appropriate to discuss.
/)
Because tesofensine is investigational and not an approved medicine, Menscape Clinic does not treat it as an off-the-shelf weight-loss product. Any discussion begins with a full medical review: your history, blood pressure, heart rate, current medications and weight-management goals. Our physicians will be candid about the limits of the evidence and will usually point first to approved, better-studied options for weight management before any experimental molecule is considered. Where a doctor judges it relevant, any use would be under close medical supervision with monitoring. The clinic does not promise outcomes, and the decision always rests with the supervising physician.
/)
Every Tesofensine protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame Tesofensine as a research-stage option and prescribe only when clinically appropriate.
No. Tesofensine is not approved by the FDA, the EMA or any major regulator for weight loss or any other use. It is an investigational drug that has completed Phase 2 trials and a Phase 3 obesity trial (reported 2018) that met its endpoints, but it has not received marketing approval from any major regulator. Its legal status varies by country, which is one reason any consideration of it must happen through a qualified physician rather than self-sourcing.
Its safety is not fully established because it has not completed full regulatory review and approval. In studies, the most-watched effects relate to its stimulant-like action on three brain chemicals, including increases in heart rate and blood pressure, and possible changes in mood or sleep. These are exactly why it is only ever discussed under medical supervision, with screening and monitoring, and why it is not suitable for men with heart conditions or certain other health issues.
No. Despite often being grouped with peptides in wellness marketing, tesofensine is a synthetic small-molecule drug taken orally. It belongs to the class of triple monoamine reuptake inhibitors, which act on brain neurotransmitter systems, and is chemically unrelated to the injectable peptides discussed elsewhere on this site.
We cannot promise any specific result, and it is important to read trial figures cautiously. In Phase 2 obesity research over 24 weeks, alongside a reduced-calorie diet, higher doses were associated with meaningful placebo-subtracted weight loss. Those are controlled-trial findings in selected patients, not a guarantee of what any individual would experience, and the drug remains unapproved.
In its trials, tesofensine was taken as a once-daily oral dose. Because it is investigational and not an approved product with a standard label, there is no officially sanctioned dosing for general use. Any regimen would be a clinical decision made and monitored by a physician, never something to set or adjust on your own.
You can have an informed, honest conversation about it. Because tesofensine is investigational, our physicians will first review your full health profile and will usually recommend approved, better-evidenced weight-management options. Whether tesofensine is even appropriate to consider is a medical judgement made case by case, and the clinic does not dispense it as a routine product. The best next step is a consultation.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)